Modulation of Pancreatic Neuroendocrine Neoplastic Cell Fate by Autophagy-Mediated Death

Sami Matrood1, Nicola de Prisco2,3, Thaddeus T Wissniowski4

  • 1Department of Visceral Thoracic and Vascular Surgery, Philipps University Marburg, Marburg, Germany.

Neuroendocrinology
|October 27, 2020
PubMed
Abstract

Insights

Pancreatic neuroendocrine neoplastic cells undergo autophagic cell death when deacetylase inhibitors are used. Restoring autophagy may offer a new therapeutic strategy for pNEN patients.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Autophagic cell death is a known mechanism in cancer therapy.
  • The role of autophagy in pancreatic neuroendocrine neoplasms (pNEN) is not well understood.
  • Investigating autophagy in pNEN could reveal new therapeutic targets.

Purpose of the Study:

  • To investigate the role of autophagy in pNEN cell death.
  • To determine if inhibiting deacetylases can induce autophagic cell death in pNEN.
  • To explore the therapeutic potential of modulating autophagy in pNEN.

Main Methods:

  • Human pNEN cells were treated with panobinostat (a deacetylase inhibitor) and bafilomycin.
  • Autophagy markers (Beclin1, LC3B) and cell death were assessed using molecular and imaging techniques.
  • Autophagosome formation, maturation, and cellular localization were analyzed via electron microscopy and live-cell imaging.

Main Results:

  • Panobinostat induced autophagic cell death in pNEN cells, characterized by autophagosome accumulation in the cytosol and nucleus.
  • Autophagy inhibition prevented cell death, while panobinostat treatment led to cellular digestion and decay.
  • Reduced autophagy marker expression was observed in human pNEN patients, particularly in metastatic cases.

Conclusions:

  • Deacetylase inhibition triggers autophagic cell death in pNEN cells by restoring and prolonging the autophagic process.
  • Targeting autophagy, specifically inducing autophagic cell death, presents a promising therapeutic strategy for pNEN.
  • Autophagy modulation could be key to improving treatment outcomes for pNEN patients.

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.9K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.5K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
8.7K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.5K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
4.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.4K